WG4 – Stakeholder relations
Working Group 4 ensures representation of all relevant stakeholders within GliMR and acts as liason from GliMR to all relevant stakeholders.
This working group is initiated to ensure lasting collaborations with stakeholders inside and outside the network.
- Liaise with stakeholders within the field of glioma or MR-imaging, including key international consortia and organisations with a focus on glioma research and/or imaging biomarkers, industry collaborators, clinical practice, local, national and European policy makers, patient organisations, relevant, established COST Action groups.
- Identify other organisations and institutes with complementary expertise and data (e.g. MRI, cognition, genetics) to actively engage with throughout the Action.
- Coordinate communications between all stakeholders.